provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeDrug ClassesSglt2 Inhibitors

FDA Warns of Serious Genital Infection Linked to SGLT2 Inhibitors for Diabetes

Ronilee Shye, PharmD, BCGP, BCACP, CDE
Published on September 13, 2018
This article is no longer being updated and some information may not be current. Visit the GoodRx Health homepage for our latest articles.

Just last week, the Food and Drug Administration (FDA) released a new warning for SGLT2 inhibitors, a class of drugs used to lower blood sugar in adults with type 2 diabetes. According to the FDA, a serious bacterial infection known as necrotizing fasciitis has been reported in the genital area of some patients taking SGLT2 inhibitors. While this condition is rare and only 12 cases have been confirmed since 2013, necrotizing fasciitis spreads rapidly and can be deadly.

A person holding a pill bottle and a tablet.
Tassii/E+ via Getty Images

This isn’t the first dangerous side effect associated with SGLT2 inhibitors. Over the past five years, the FDA has released five safety communications about risks related to SGLT2 inhibitors, ranging from decreased bone density and increased acid in the blood to urinary tract infections and leg and foot amputations.

What are SGLT2 inhibitors?

SGLT2 inhibitors reduce blood sugar levels by preventing the kidneys from reabsorbing excess glucose so it’s excreted in the urine.

Drugs in this class include Invokana, Jardiance, Farxiga, Invokamet, Synjardy and Steglujan.

What is necrotizing fasciitis?

Also known as Fournier’s gangrene, necrotizing fasciitis is a rare bacterial infection that spreads quickly in the body and can cause death. Symptoms are broken down into two periods: early and late. Early symptoms of necrotizing fasciitis include fever, pain, and red or swollen skin, while late symptoms include ulcers, blisters, changes in color of the skin, dizziness, tiredness, diarrhea and nausea.

I’m taking an SGLT2 inhibitor. What should I do?

For all SGLT2 inhibitors, the FDA is requiring that a new warning for necrotizing fasciitis be added to both the prescribing information document for health providers and the patient medication guide.

If you are taking an SGLT2 inhibitor and begin to experience any of the symptoms above and/or swelling of the genital area, seek medical attention immediately. Once necrotizing fasciitis appears, it can progress to life-threatening symptoms within days, so understanding the warning signs and contacting your healthcare provider quickly is key.

why trust our exports reliability shield

Why trust our experts?

Ronilee Shye, PharmD, BCGP, BCACP, CDE
Roni is an expert in clinical pharmacy and patient care. She received her doctorate in pharmacy from Duquesne University in Pittsburgh, Pennsylvania; is board-certified in geriatrics and ambulatory care pharmacy; and is licensed to practice pharmacy in Ohio, Pennsylvania, and Florida.
Benita Lee, MPH
Edited by:
Benita Lee, MPH
Benita Lee, MPH, is director of content and operations at GoodRx and contributes to content strategy and process management across editorial and product initiatives. She is passionate about building collaborative teams and has a deep interest in using research to improve health outcomes in innovative and sustainable ways.

Was this page helpful?

Learn How to Lower Your A1C

Join our 12-week newsletter series that has the lifestyle, diet, and medication information you need to help lower your A1C.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.